Cantech Letter
Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Cantech Letter

Tap here to search for stock quotes, financial statistics and more.

or

  • All
  • Software
  • Cannabis
  • Fintech
  • Life Sciences
  • AI
  • Smallcap
  • Analysts
  • More
    • Hardware
    • Gaming
    • Interviews
    • Science
    • eCommerce
    • Lists and Data
    • Wireless
    • RIM
    • Stock Guides
Youtube

Analysts

XTRA stock
Analysts Security SmallCap xtra
This small Canadian security stock is a buy, analyst says

Ventum Capital Markets analyst Amr Ezzat maintained a “Buy” rating and C$1.00 target price for Xtract One Technologies (Xtract One Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:XTRA) in a Sept. 8 corporate update, pointing to growing traction in the U.S. education sector as a meaningful new growth driver. “We continue to view Xtract as […]

Enghouse
Analysts Software engh
RBC trims price target on Enghouse Systems

As reported by the Globe and Mail, on Sept. 8, RBC Dominion Securities analyst Paul Treiber cut his target for Enghouse Systems (Enghouse Systems Stock Quote, Chart, News, Analysts, Financials TSX:ENGH) to $24.00 from $26.00 while maintaining a “Sector Perform” rating, citing continued weak organic growth and a need for more capital deployment on acquisitions. […]

facebook Share twitter Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

Analysts Software vxtr

Voxtur Analytics has a 60 per cent upside, says Eight Capital

October 21, 2021

Eight Capital analyst Christian Sgro remains bullish in his support for Voxtur Analytics (Voxtur Ana...

AI Analysts CGN

Cognetivity Neurosciences hits key catalyst, Echelon Capital says

October 20, 2021

Stefan Quenneville of Echelon Capital Markets likes the progress being made by Cognetivity Neurosci...

Analysts Cannabis hiti

High Tide becoming the Costco of cannabis, ATB Capital says

October 20, 2021

ATB Capital Markets analyst Frederico Gomes believes High Tide (High Tide Stock Quote, Charts, News...

Analysts Cleantech LOOP

Strong economics from Loop Industries, says Paradigm

October 20, 2021

Paradigm Capital analysts J. Marvin Wolff and Corey Hammill like what they see out of Loop Industrie...

SYZ stock
Analysts Software syz

Sylogist has an 86 per cent upside, says Echelon

October 20, 2021

Echelon Capital Markets analyst Amr Ezzat continues to stick with Sylogist (Sylogist Stock Quote, Ch...

Auxly Cannabis
Analysts Cannabis xly

Auxly Cannabis is eating up market share, says Research Capital

October 19, 2021

Research Capital Corporation analyst Venkata Velagapudi likes what he sees from Auxly Cannabis (Aux...

Analysts Hardware bln

Blackline Safety is ready for growth, says PI Financial

October 19, 2021

Kris Thompson of PI Financial is holding the line on Blackline Safety (Blackline Safety Stock Quote,...

Analysts Pharma and Biotech ngen

NervGen Pharma’s first data in trial looks good, says iA Capital

October 19, 2021

Chelsea Stellick of iA Capital Markets is staying bullish on biopharm company NervGen Pharma (NervG...

Analysts IT Software so

Softchoice is still a pass, says Laurentian Bank

October 19, 2021

Laurentian Bank Securities analyst Nick Agostino’s stance on Softchoice (Softchoice Stock Quote, C...

antibe therapeutics
Analysts Pharma and Biotech ate

Antibe Therapeutics has a 159 per cent upside, says Echelon

October 19, 2021

Stefan Quenneville of Echelon Capital Markets has lowered his expectations for Antibe Therapeutics (...

Valens
Analysts Cannabis vlns

The Valens Company is set up well for 2022, ATB Capital says

October 16, 2021

The stock is down plenty in recent months but ATB Capital Markets analyst Frederico Gomes still sees...

EnWave
Analysts Cannabis enw

EnWave is making global inroads, iA Capital reports

October 15, 2021

Neil Linsdell of iA Capital Markets believes EnWave Corp (EnWave Stock Quote, Chart, News, Analysts,...

Analysts Cannabis cl

Cresco Labs is bulking up, says ATB Capital

October 15, 2021

Despite the pullback across the sector, ATB Capital Markets analyst Kenric Tyghe is staying positive...

Analysts Pharma and Biotech th

Theratechnologies has an 84 per cent upside, says Research Capital

October 14, 2021

André Uddin from Research Capital Corporation is still tight with Theratechnologies (Theratechnolog...

Analysts Health Life Sciences ngen

Inflection points upcoming for NervGen Pharma, says Paradigm Capital

October 14, 2021

Paradigm Capital analyst Scott McAuley believes NervGen Pharma (NervGen Pharma Stock Quote, Chart, N...

OTRK stock
Analysts Health crbk doc well

Three Canadian digital health stocks with Buy ratings

October 14, 2021

It’s a space that’s expected to see accelerated growth for years to come as physicians, clinics,...

Analysts Cannabis db faf ndva

Three under-the-radar Canadian cannabis stocks for your portfolio

October 14, 2021

Cannabis seems to be no one’s favourite game at the moment, with the sector having lost pretty muc...

Analysts Life Sciences DNA

Ginkgo Bioworks is on the forefront of a revolution, Raymond James says

October 13, 2021

Raymond James analyst Rahul Sarugaser has turned his attention to Ginkgo Bioworks Holdings (Ginkgo B...

Previous 1 … 160 161 162 … 387 Next
facebook Share twitter Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
WELL stock

WELL Health Technologies’ opportunity is huge, Stifel says

August 22, 2025
ROMJ stock

Rubicon Organics wins price target raise at Haywood

August 20, 2025

This analyst just raised his price target on WELL Health Technologies

August 18, 2025
OGI stock

Is Organigram stock a buy?

August 15, 2025
LSPD stock

Lightspeed “showing encouraging signs”, ATB Capital says

August 5, 2025
  • 1 (604) 720-2684
    3860 Dollarton Hwy, North Vancouver, BC V7G 1A2
    Copyright © · Cantech Communications
    Financial Market Data powered by QuoteMedia © QuoteMedia, Inc.
    Data delayed 15 minutes unless otherwise indicated.

    • About
    • Stock Guides
    • Stock Wiki
    • Advertise
    • Terms and Conditions
    • Privacy Policy